Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis

CuraVac · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
conceptcvfirstproofsafety
myasthenia gravis, cv-mg01 therapeutic vaccine, acetylcholine receptor mimetic peptides, safety, immunogenic response, first-in-human, proof-of-concept, myasterix, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 846146
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.